Pro-inflammatory cytokine release and mediation of the acute phase protein response in fulminant hepatic failure

Intensive Care Medicine

Volumn 24, Issue 3, 1998, Pages 224-229

  Wigmore, S J ^a   Walsh, T S ^a   Lee, A ^a   Ross, J A ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

C reactive protein; Fulminant hepatic failure; Interleukin 6; Lipopolysaccharide; Peripheral blood mononuclear cells; Tumour necrosis factor

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ACUTE PHASE RESPONSE; ADOLESCENT; ADULT; AGED; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LIVER CELL; LIVER FAILURE; MONONUCLEAR CELL; SUPERNATANT;

EID: 0031918139     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050554     Document Type: Article

References (25)

1. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R. Heinrich PC (1990) Acute phase response of human hepatocytes: regulation of acute phase protein synthesis by interleukin-6. Hepatology 12: 1179-1186
2. Heinrich PC, Castell JV, Andus T (1990) Interleukin-6 and the acute phase response. Biochem J 265: 621-636
3. Auger M, Ross JA (1991) The Biology of the Macrophage. In: Lewis C, McGee JO'D (eds) The natural immune system. Volume II: The Macrophage. Oxford University Press, Oxford, pp 1-74
4. Majello B, Arcone R, Toniatti C, Giliberto G (1990) Constitutive and IL-6-induced nuclear factors that interact with the human C-reactive protein promoter. EMBO J 9: 457-465
5. Morrone G, Giliberto G, Oliviero S, Arcone R, Dente L, Content J, Cortese R (1988) Recombinant interleukin-6 regulates transcriptional activation of a set of human acute phase genes. J Biol Chem 263: 12554-12558
6. O'Riordain MG, Ross JA, Fearon KC, Maingay J, Farouk M, Garden OJ, Carter DC (1995) Insulin and the counter-regulatory hormones influence acute phase protein production in the human hepatocyte. Am J Physiol 269: E323-E330
7. Kushner I, Ganapathi M, Schultz D (1989) The acute phase response is mediated by heterogenous mechanisms. Ann NY Acad Sci 557: 19-29
8. Reeds PJ, Fjeld JR, Jahoor F (1994) Do the differences between the amino acid compositions of acute-phase and skeletal muscle proteins have a bearing on nitrogen loss in traumatic states? J Nutr 124: 906-910
9. Goldie AS, Fearon KC, Ross JA, Barclay GR, Jackson RE, Grant IS, Ramsay G, Blyth AS, Howie JC (1995) Natural cytokine antagonists and endogenous anti-endotoxin core antibodies in sepsis syndrome. JAMA 274: 172-177
10. Falconer JS, Fearon KCH, Plester CE, Ross JA, Carter DC (1994) Cytokines, the acute phase response and energy expenditure in weight-losing patients with pancreatic cancer. Ann Surg 219: 325-331
11. Falconer JS, Fearon KCH, Ross JA, Elton RE, Garden OJ, Wigmore SJ, Carter DC (1995) The acute phase response and survival duration in pancreatic cancer. Cancer 75: 2077-2081
12. Schneewiess B, Pammer J, Madl C, Kramer L, Kranz A, Ferenci P, Druml W, Grimm G, Lenz K, Gangl A (1993) Energy metabolism in acute hepatic failure. Gastroenterology 105: 1515-1521
13. Izumi S, Hughes RD, Langley PG, Pernambuco JR, Williams R (1994) Extent of the acute phase response in fulminant hepatic failure. Gut 35: 982-986
14. Highton J. Hessian P (1984) A solid phase enzyme immunoassay for C-reactivc protein: clinical value and the effect of rheumatoid factor. J Immunol Methods 68: 185-192
15. Rosner B (1986) Fundamentals of biostatistics. PWS Publishers, Boston, pp 379-382
16. Andus T, Geiger T, Hirano T, Kishimoto T, Heinrich PC (1988) Action of recombinant human interleukin-6, interleukin-1 beta and tumour necrosis factor alpha on the mRNA induction of acute phase proteins. Eur J Immunol 18: 739-746
17. Wigmore SJ, Fearon KCH, Ross JA (1997) Modulation of human hepatocyte acute phase protein production in vitro by n-3 and n-6 polyunsaturated fatty acids. Ann Surg 225: 103-111
18. Fiaccadori F, Pedretti G, Ferrari C, Pizzaferri P, Riggio O, Orlandi N, Pezzarossa A (1991) Insulin and glucagon levels in fulminant hepatic failure in man. Dig Dis Sci 36: 801-808
19. Ertel W, Kremer JP, Kenney J, Steckholzer U, Jarrar D, Trentz O, Schildherg FW (1995) Downregulation of proin-flammatory cytokine release in whole blood from septic patients. Blood 85: 1341-1347
20. Harrison P, Degen SJ, Williams R, Farzaneh F (1994) Hepatic expression of hepatocyte-growth-factor-like/macrophage stimulating protein mRNA in fulminant hepatic failure. Lancet 344: 27-29
21. Blazka ME, Wilmer JL, Holladay SD, Wilson RE, Luster MI (1995) Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 133: 43-52
22. Docke WD, Randow F, Syrhe U, Krausch D, Asadullah K, Reinke P, Volk HD, Kox W (1997) Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nature Med 3: 678-681
23. Kakumu S, Okumura A, Ishikawa T, Iwata K, Yano M, Yoshioka K (1997) Production of interleukins 10 and 12 by peripheral blood mononuclear cells (PBMC) in chronic hepatitis C virus (HCV) infection. Clin Exp Immunol 108: 138-143
24. Sekiyama KD, Yoshiba M, Thomson AW (1994) Circulating proinflammatory cytokines (IL-1 beta. TNF-alpha. and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol 98-71-77
25. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NK-kB activity through induction of 1kB synthesis. Science 270: 286-290